Cargando…

Adult attention-deficit/hyperactivity disorder symptoms, cognitive dysfunction and quality of life in high-dose use of benzodiazepine and Z-drug

High-dose use of benzodiazepines (BZDs) and Z-drugs was found to be associated with adult attention deficit/hyperactivity disorder (ADHD) and multidomain cognitive deficits, but the interplay between these factors and its effect on quality of life (QoL) is unclear. We explored (a) whether cognitive...

Descripción completa

Detalles Bibliográficos
Autores principales:	Federico, Angela, Mantovani, Elisa, Casari, Rebecca, Bertoldi, Anna, Lugoboni, Fabio, Tamburin, Stefano
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Vienna 2020
Materias:	Psychiatry and Preclinical Psychiatric Studies - Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8295124/ https://www.ncbi.nlm.nih.gov/pubmed/33331955 http://dx.doi.org/10.1007/s00702-020-02285-w

Ejemplares similares

High-Dose Dependence and Cognitive Side Effects to Medical Prescription of Etizolam
por: Tamburin, Stefano, et al.
Publicado: (2020)

Driving and attention deficit hyperactivity disorder
por: Fuermaier, Anselm B. M., et al.
Publicado: (2015)

Detoxification Improves Multidomain Cognitive Dysfunction in High-Dose Benzodiazepine Abusers
por: Federico, Angela, et al.
Publicado: (2020)

Electrophysiological underpinnings of dysfunctional inhibitory control in adults with attention-deficit/hyperactivity disorder: evidence for reduced NoGo anteriorization
por: Papp, Szilvia, et al.
Publicado: (2023)

Tryptophan modulation in individuals with attention deficit hyperactivity disorder: a systematic review
por: Dinu, Larisa Maria, et al.
Publicado: (2022)

Atypical resting-state gamma band trajectory in adult attention deficit/hyperactivity disorder
por: Tombor, László, et al.
Publicado: (2021)

The impact of preschool child and maternal attention-deficit/hyperactivity disorder (ADHD) symptoms on mothers’ perceived chronic stress and hair cortisol
por: Szép, Anna, et al.
Publicado: (2021)

Therapeutic drug monitoring of atomoxetine in children and adolescents with attention-deficit/ hyperactivity disorder: a naturalistic study
por: Ruppert, Katrin, et al.
Publicado: (2022)

Long-term changes in serum levels of lipoproteins in children and adolescents with attention-deficit/hyperactivity disorder (ADHD)
por: Huber, Franziska, et al.
Publicado: (2023)

Norepinephrine influences the circadian clock in human dermal fibroblasts from study participants with a diagnosis of attention-deficit hyperactivity disorder
por: Palm, Denise, et al.
Publicado: (2021)

Atomoxetine and circadian gene expression in human dermal fibroblasts from study participants with a diagnosis of attention-deficit hyperactivity disorder
por: Faltraco, Frank, et al.
Publicado: (2021)

Polysubstance Use Patterns Among High Dose Benzodiazepine Users: A Latent Class Analysis and Differences Between Male and Female Use
por: Zamboni, Lorenzo, et al.
Publicado: (2022)

Continuous Infusion of Flumazenil in the Management of Benzodiazepines Detoxification
por: Benini, Anna, et al.
Publicado: (2021)

A candidate gene investigation of methylphenidate response in adult attention-deficit/hyperactivity disorder patients: results from a naturalistic study
por: Hegvik, Tor-Arne, et al.
Publicado: (2016)

Association study and a systematic meta-analysis of the VNTR polymorphism in the 3′-UTR of dopamine transporter gene and attention-deficit hyperactivity disorder
por: Grünblatt, Edna, et al.
Publicado: (2019)

Addiction of High Dose of Benzodiazepine: Verona Detox Approach With Flumazenil
por: Casari, Rebecca, et al.
Publicado: (2022)

Growth rates of human induced pluripotent stem cells and neural stem cells from attention-deficit hyperactivity disorder patients: a preliminary study
por: Yde Ohki, Cristine Marie, et al.
Publicado: (2023)

Determinants of Quality of Life in High-Dose Benzodiazepine Misusers
por: Tamburin, Stefano, et al.
Publicado: (2017)

Dependence liability of lormetazepam: are all benzodiazepines equal? The case of the new i.v. lormetazepam for anesthetic procedures
por: Horowski, Reinhard
Publicado: (2020)

Viloxazine in the Treatment of Attention Deficit Hyperactivity Disorder
por: Edinoff, Amber N., et al.
Publicado: (2021)

New Insights on the Effects of Methylphenidate in Attention Deficit Hyperactivity Disorder
por: Pitzianti, Maria Bernarda, et al.
Publicado: (2020)

Association of Prenatal Exposure to Benzodiazepines and Z-Hypnotics With Risk of Attention-Deficit/Hyperactivity Disorder in Childhood
por: Sundbakk, Lene Maria, et al.
Publicado: (2022)

Reward-Related Dysfunctions in Children Developing Attention Deficit Hyperactivity Disorder—Roles of Oppositional and Callous-Unemotional Symptoms
por: Schloß, Susan, et al.
Publicado: (2021)

Benzodiazepines in sport, an underestimated problem: Recommendations for sports medicine physicians’ practice
por: Zandonai, Thomas, et al.
Publicado: (2022)

Sustained attention in adult ADHD: time-on-task effects of various measures of attention
por: Tucha, Lara, et al.
Publicado: (2015)

Long-term use of benzodiazepines in chronic insomnia: a European perspective
por: Soyka, Michael, et al.
Publicado: (2023)

Altered urinary tetrahydroisoquinoline derivatives in patients with Tourette syndrome: reflection of dopaminergic hyperactivity?
por: Capetian, Philipp, et al.
Publicado: (2020)

Temperament Dimensions and Awakening Cortisol Levels in Attention-Deficit/Hyperactivity Disorder
por: Carta, Alessandra, et al.
Publicado: (2022)

Why the Diagnosis of Attention Deficit Hyperactivity Disorder Matters
por: Hamed, Alaa M., et al.
Publicado: (2015)

Attention Deficit Hyperactivity Disorder in the Light of the Epigenetic Paradigm
por: Schuch, Viviane, et al.
Publicado: (2015)

Epigenetics and Attention-Deficit/Hyperactivity Disorder: New Perspectives?
por: Mirkovic, Bojan, et al.
Publicado: (2020)

Hyperfocus symptom and internet addiction in individuals with attention-deficit/hyperactivity disorder trait
por: Ishii, Sayuri, et al.
Publicado: (2023)

The association between different sources of distraction and symptoms of attention deficit hyperactivity disorder
por: Osborne, Jahla B., et al.
Publicado: (2023)

A 4-Year Follow-Up Study of Attention-Deficit Hyperactivity Symptoms, Comorbidities, and Psychostimulant Use in a Brazilian Sample of Children and Adolescents with Attention-Deficit/Hyperactivity Disorder
por: Palma, Sonia M. M., et al.
Publicado: (2015)

Gray Matter Network Associated With Attention in Children With Attention Deficit Hyperactivity Disorder
por: Wang, Xing-Ke, et al.
Publicado: (2022)

Identifying potentially marker symptoms of attention-deficit/hyperactivity disorder
por: Arias, Víctor B., et al.
Publicado: (2018)

Low serum sphingolipids in children with attention deficit-hyperactivity disorder
por: Henríquez-Henríquez, Marcela P., et al.
Publicado: (2015)

Alterations of Growth Factors in Autism and Attention-Deficit/Hyperactivity Disorder
por: Galvez-Contreras, Alma Y., et al.
Publicado: (2017)

Attention Deficit Hyperactivity Disorder: Association With Obesity and Eating Disorders
por: Ravi, Prithvi, et al.
Publicado: (2020)

Can biomarkers be used to diagnose attention deficit hyperactivity disorder?
por: Chen, Hui, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_nu0nmb1ekss2nd73fijd162h5g